Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 22, Issue 6, 2016, Pages 1450-1455

  Herrera Deguise, Claudia ^a   Casellas, Francesc ^a   Robles, Virginia ^a   Navarro, Ester ^a   Borruel, Natalia ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

health related quality of life; inflammatory bowel disease; iron deficiency

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REMISSION; ULCERATIVE COLITIS; BLOOD; DEFICIENCY; METABOLISM; PERCEPTION; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; IRON; MALE; PERCEPTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TRANSFERRIN;

EID: 84970969206     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000768     Document Type: Article

References (30)

1. Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11:488-496.
2. Wolfe BJ, Sirois FM. Beyond standard quality of life measures: the subjective experiences of living with inflammatory bowel disease. Qual Life Res. 2008;17:877-886.
3. Casellas F, Lopez-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002;11:775-781.
4. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6:142-150; discussion 151.
5. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):44S-49S.
6. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn?s disease. Aliment Pharmacol Ther. 2006;24:1507-1523.
7. Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012;18: 1961-1981.
8. Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595.
9. Waldvogel-Abramowski S, Waeber G, Gassner C, et al. Physiology of iron metabolism. Transfus Med Hemother. 2014;41:213-221.
10. WHO.INT. WHO Micronutrient Deficiencies Iron Deficiency Anemia. 2015. Available at: http://www.who.int/nutrition/topics/ida/en/. Accessed March 2016.
11. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545-1553.
12. Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211-222.
13. van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32:131-143.
14. Brownlie T, Utermohlen V, Hinton PS, et al. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr. 2004;79:437-443.
15. Krayenbuehl PA, Battegay E, Breymann C, et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011;118:3222-3227.
16. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47-52.
17. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123-130.
18. Gisbert JP, Bermejo F, Pajares R, et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis. 2009;15:1485-1491.
19. Comin-Colet J, Enjuanes C, Gonzalez G, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013;15:1164-1172.
20. Lopez-Vivancos J, Casellas F, Badia X, et al. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn?s disease. Digestion. 1999;60:274-280.
21. Huaman JW, Casellas F, Borruel N, et al. Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a Normal health related quality of life. J Crohns Colitis. 2010;4:637-641.
22. Jones DE, Gray JC, Newton J. Perceived fatigue is comparable between different disease groups. QJM. 2009;102:617-624.
23. Castillo-Cejas MD, Robles V, Borruel N, et al. Questionnaries for measuring fatigue and its impact on health perception in inflammatory bowel disease. Rev Esp Enferm Dig. 2013;105:144-153.
24. Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846-853.e1-2.
25. Favrat B, Balck K, Breymann C, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women-PREFER a randomized, placebo-controlled study. PLoS One. 2014;9:e94217.
26. Goldenberg BA, Graff LA, Clara I, et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease?. Am J Gastroenterol. 2013;108:1392-1397.
27. Beigel F, Lohr B, Laubender RP, et al. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Digestion. 2012;85:47-54.
28. Cekic C, Ipek S, Aslan F, et al. The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract. 2015;2015: 582163.
29. Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4:537-545.
30. Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315-325.